ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesL12.3

L12.3

Non-billable

Acquired epidermolysis bullosa

BILLABLE STATUSNo
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 L12.3 is a used to indicate a diagnosis of acquired epidermolysis bullosa.

Key Diagnostic Point:

Acquired epidermolysis bullosa (AEB) is a rare dermatological condition characterized by the formation of blisters on the skin and mucous membranes due to mechanical trauma or friction. Clinically, patients present with fragile skin that easily develops blisters, leading to painful erosions and potential secondary infections. The condition can affect various anatomical areas, including the extremities, trunk, and mucosal surfaces. Disease progression may vary; some patients experience localized blistering, while others may have widespread involvement that can lead to significant morbidity. Diagnostic considerations include a thorough clinical examination, patient history, and, in some cases, skin biopsy to differentiate AEB from inherited forms of epidermolysis bullosa. Immunofluorescence studies may also be utilized to assess the presence of specific antibodies. Early diagnosis and management are crucial to prevent complications such as infection and scarring.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Requires differentiation from inherited forms and other blistering disorders.
  • Treatment complexity: Management may involve wound care, pain management, and prevention of secondary infections.
  • Documentation requirements: Detailed clinical notes are essential to support diagnosis and treatment.
  • Coding specificity: Requires accurate coding to reflect the specific type and cause of epidermolysis bullosa.

Audit Risk Factors

  • Common coding errors: Misclassification with inherited forms or other skin disorders.
  • Documentation gaps: Incomplete patient history or lack of detailed clinical notes.
  • Billing challenges: Potential denials if documentation does not clearly support the diagnosis.

Specialty Focus

Medical Specialties

Dermatology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Wound care management

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related ICD-10 Codes

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Acquired epidermolysis bullosa can significantly impact patient quality of life due to chronic pain, frequent medical visits, and potential complications such as infections. Understanding the epidemiology of AEB is crucial, as it may be associated with underlying systemic conditions. Effective management can improve healthcare utilization patterns and reduce the burden on healthcare systems, emphasizing the need for awareness and early intervention in affected populations.

ICD-9 vs ICD-10

Acquired epidermolysis bullosa can significantly impact patient quality of life due to chronic pain, frequent medical visits, and potential complications such as infections. Understanding the epidemiology of AEB is crucial, as it may be associated with underlying systemic conditions. Effective management can improve healthcare utilization patterns and reduce the burden on healthcare systems, emphasizing the need for awareness and early intervention in affected populations.

Reimbursement & Billing Impact

Acquired epidermolysis bullosa can significantly impact patient quality of life due to chronic pain, frequent medical visits, and potential complications such as infections. Understanding the epidemiology of AEB is crucial, as it may be associated with underlying systemic conditions. Effective management can improve healthcare utilization patterns and reduce the burden on healthcare systems, emphasizing the need for awareness and early intervention in affected populations.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for L00-L99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for L00-L99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by L12.3?

L12.3 specifically covers acquired epidermolysis bullosa, which can arise from various causes such as autoimmune disorders, drug reactions, or physical trauma. It is important to differentiate it from inherited forms of epidermolysis bullosa.

When should L12.3 be used instead of related codes?

L12.3 should be used when the blistering condition is acquired rather than inherited. If the patient has a known history of autoimmune disease or has experienced trauma leading to blister formation, L12.3 is appropriate.

What documentation supports L12.3?

Documentation should include a detailed clinical assessment, history of skin fragility, any precipitating factors, and results from diagnostic tests such as skin biopsies or immunofluorescence studies.